Defects of antithrombin III, protein C, and plasminogen in Wilson's disease with brainstem infarction
Suzuki, M.; Shioya, K.; Yamamura, Y.; Kurihara, T.; Matsukura, S.
Rinsho Shinkeigaku 27(10): 1244-1247
1987
ISSN/ISBN: 0009-918X PMID: 3440344 Document Number: 297217
Document emailed within 1 workday
Related Documents
Stoica, E.; Voiculescu, V. 1984: Replicating brainstem symptoms by head down tilting in hypertensive patients with brainstem infarction Neurologie et Psychiatrie 22(2): 129-136Glas-Greenwalt, P.; Hall, J.M.; Panke, T.W.; Kant, K.S.; Allen, C.M.; Pollak, V.E. 1986: Fibrinolysis in health and disease: abnormal levels of plasminogen activator, plasminogen activator inhibitor, and protein C in thrombotic thrombocytopenic purpura Journal of Laboratory and Clinical Medicine 108(5): 415-422
Patton, D.F.; Harper, J.L.; Wooldridge, T.N.; Gordon, B.G.; Coccia, P.; Haire, W.D. 1996: Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate Bone Marrow Transplantation 17(3): 443-447
Nalçaci, M.; Pekçelen, Y. 1998: Antithrombin III, protein C and protein S plasma levels in patients with Behçet's disease Journal of International Medical Research 26(4): 206-208
Andreotti, F.; Hackett, D.R.; Haider, A.W.; Roncaglioni, M.C.; Davies, G.J.; Beacham, J.L.; Kluft, C.; Maseri, A. 1992: Von Willebrand factor, plasminogen activator inhibitor-1 and C-reactive protein are markers of thrombolytic efficacy in acute myocardial infarction Thrombosis and Haemostasis 68(6): 678-682
Yuzbasiyan-Gurkan, V.; Brewer, G.J.; Abrams, G.D.; Main, B.; Giacherio, D. 1989: Treatment of Wilson's disease with zinc. V. Changes in serum levels of lipase, amylase, and alkaline phosphatase in patients with Wilson's disease Journal of Laboratory and Clinical Medicine 114(5): 520-526
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Degli Esposti, A.; Antener, I.; Ambrosioni, G.; Bonfiglioli, G. 1976: Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage Minerva Pediatrica 28(34): 2063-2086
Wolk, L.A.; Wilson, R.F.; Burdick, M.; Selik, N.; Brown, J.; Starricco, A.; Mammen, E.F. 1985: Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass American Surgeon 51(6): 309-313
Ogawa, K.; Baba, S.; Funazaki, K.; Nakanishi, K.; Hirohashi, K.; Suzuki, E.; Tamura, M. 1984: The values of plasminogen, antithrombin III, factor XIIi and fibrinogen according to age and sex Rinsho Byori. Japanese Journal of Clinical Pathology 32(6): 679-682
Kamoun, P.; Cadoudal, M.; Rabier, D.; Jérôme, H. 1986: Detection of Wilson's disease in sibs of a patient with Wilson's disease Clinical Chemistry 32(2): 392
Habib, S.S.; Abdel Gader, A.G.M.; Kurdi, M.I.; Suriya, M.O.; Al Aseri, Z. 2012: Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina JPMA. Journal of the Pakistan Medical Association 62(7): 681-685
Mirka Illić; Majki, N.ć-Singh; Lali, K.ć 2002: Plasminogen Activator Inhibitor in Patients with Acute Myocardial Infarction and Re-Infarction in Syndrome X Clinical Laboratory 48(3-4): 125-128
Perry, J.F.; Siefring, G.E.; Reider, M.C.; Coleman, P.L.; Wehrly, J.A. 1983: Development and analytical performance of automated tests for antithrombin IIi and plasminogen on the du Pont aca analyzer Clinical Chemistry 29(4): 609-613
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Qian, J.; Pei, Q.; Jing, R.; Xue, L.; Dong, X.; Ren, G.; Feng, L.; Che, F. 2022: Effects of butylphthalide on the levels of serum C-reactive protein, Parkinson disease protein 7 and neurotrophin-3 and neurological function in patients with acute cerebral infarction Pakistan Journal of Pharmaceutical Sciences 35(1(Special): 349-354
Baele, G.; Kaufman, J.M.; Thiery, M.; Vermeulen, A.; Barbier, F. 1981: Plasminogen, fibrinogen, alpha 2-antiplasmin and antithrombin-III levels during a single cycle of a combined oral contraceptive regime Acta Clinica Belgica 36(6): 280-285
Kuwabara, S.; Kojima, S. 1993: MRi in brainstem infarction Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 737-742
Wencel, K. 1992: Natural factors inhibiting blood coagulation (antithrombin III, protein C and protein S) Polski Tygodnik Lekarski 47(16-17): 377-380
Costallat, L.T.; Ribeiro, C.C.; Annichino-Bizzacchi, J.M. 1998: Antithrombin, protein S and protein C and antiphospholipid antibodies in systemic lupus erythematosus Sangre 43(5): 345-348